127 related articles for article (PubMed ID: 38936562)
1. Human urinary excretion kinetics of the antimycotic climbazole: Biomonitoring of two new metabolites after oral and dermal dosage.
Schönrath I; Schmidtkunz C; Ebert KE; Küpper K; Brüning T; Koch HM; Leng G
Toxicol Lett; 2024 Jun; ():. PubMed ID: 38936562
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of novel cosmetic shampoo formulations against Malassezia species: Preliminary results of anti-dandruff shampoo formulations.
Ergin Ç; Kurt Ö; Türkoğlu M; Sevinç H; Akbaba G
J Cosmet Dermatol; 2024 Jun; 23(6):2078-2083. PubMed ID: 38544350
[TBL] [Abstract][Full Text] [Related]
3. Human metabolism and excretion kinetics of the surfactant 2,4,7,9-tetramethyl-5-decyne-4,7-diol (TMDD) after oral and dermal administration.
Pluym N; Roegner N; Peschel O; Leibold E; Scherer G; Scherer M
Arch Toxicol; 2023 Sep; 97(9):2419-2428. PubMed ID: 37392209
[TBL] [Abstract][Full Text] [Related]
4. A validated LC-MS/MS method for the quantification of climbazole metabolites in human urine.
Schmidtkunz C; Küpper K; Gries W; Leng G
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Mar; 1173():122677. PubMed ID: 33848799
[TBL] [Abstract][Full Text] [Related]
5. Human metabolism and urinary excretion kinetics of di-n-butyl adipate (DnBA) after oral and dermal administration in three volunteers.
Ringbeck B; Bury D; Gotthardt A; Hayen H; Otter R; Weiss T; Brüning T; Koch HM
Toxicol Lett; 2021 Jun; 343():11-20. PubMed ID: 33640488
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the genotoxicity of the imidazole antifungal climbazole: comparison to published results for other azole compounds.
Pérez-Rivera AA; Hu T; Aardema MJ; Nash JF
Mutat Res; 2009 Jan; 672(1):27-39. PubMed ID: 18950734
[TBL] [Abstract][Full Text] [Related]
7. Human metabolism and excretion kinetics of the fragrance 7-hydroxycitronellal after a single oral or dermal dosage.
Stoeckelhuber M; Krnac D; Pluym N; Scherer M; Peschel O; Leibold E; Scherer G
Int J Hyg Environ Health; 2018 Mar; 221(2):239-245. PubMed ID: 29108680
[TBL] [Abstract][Full Text] [Related]
8. [Clinical effectiveness and tolerance of climbazole containing dandruff shampoo in patients with seborrheic scalp eczema].
Wigger-Alberti W; Kluge K; Elsner P
Praxis (Bern 1994); 2001 Aug; 90(33):1346-9. PubMed ID: 11534318
[TBL] [Abstract][Full Text] [Related]
9. Rheology of Dead Sea shampoo containing the antidandruff climbazole.
Abu-Jdayil B; Mohameed HA
Int J Cosmet Sci; 2004 Dec; 26(6):281-9. PubMed ID: 18492152
[TBL] [Abstract][Full Text] [Related]
10. Sensitive and simultaneous quantification of zinc pyrithione and climbazole deposition from anti-dandruff shampoos onto human scalp.
Chen G; Miao M; Hoptroff M; Fei X; Collins LZ; Jones A; Janssen HG
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1003():22-6. PubMed ID: 26397749
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a piroctone olamine/climbazol shampoo in comparison with a zinc pyrithione shampoo in subjects with moderate to severe dandruff.
Schmidt-Rose T; Braren S; Fölster H; Hillemann T; Oltrogge B; Philipp P; Weets G; Fey S
Int J Cosmet Sci; 2011 Jun; 33(3):276-82. PubMed ID: 21272039
[TBL] [Abstract][Full Text] [Related]
12. Human metabolism and urinary excretion kinetics of the UV filter Uvinul A plus® after a single oral or dermal dosage.
Stoeckelhuber M; Scherer M; Peschel O; Leibold E; Bracher F; Scherer G; Pluym N
Int J Hyg Environ Health; 2020 Jun; 227():113509. PubMed ID: 32174481
[TBL] [Abstract][Full Text] [Related]
13. Simulation of urinary excretion of 1-hydroxypyrene in various scenarios of exposure to polycyclic aromatic hydrocarbons with a generic, cross-chemical predictive PBTK-model.
Jongeneelen F; ten Berge W
Int Arch Occup Environ Health; 2012 Aug; 85(6):689-702. PubMed ID: 22038087
[TBL] [Abstract][Full Text] [Related]
14. Toxicokinetics of a urinary metabolite of tebuconazole following controlled oral and dermal administration in human volunteers.
Oerlemans A; Verscheijden LFM; Mol JGJ; Vermeulen RCH; Westerhout J; Roeleveld N; Russel FGM; Scheepers PTJ
Arch Toxicol; 2019 Sep; 93(9):2545-2553. PubMed ID: 31359083
[TBL] [Abstract][Full Text] [Related]
15. Toxicokinetics of homosalate in humans after dermal application: applicability of oral-route data for exposure assessment by human biomonitoring.
Ebert KE; Griem P; Weiss T; Brüning T; Hayen H; Koch HM; Bury D
Arch Toxicol; 2024 May; 98(5):1383-1398. PubMed ID: 38485782
[TBL] [Abstract][Full Text] [Related]
16. Development of a urinary biomarker for exposure to the organophosphate propetamphos: data from an oral and dermal human volunteer study.
Garfitt SJ; Jones K; Mason HJ; Cocker J
Biomarkers; 2002; 7(2):113-22. PubMed ID: 12101631
[TBL] [Abstract][Full Text] [Related]
17. Climbazole increases expression of cornified envelope proteins in primary keratinocytes.
Pople JE; Moore AE; Talbot DC; Barrett KE; Jones DA; Lim FL
Int J Cosmet Sci; 2014 Oct; 36(5):419-26. PubMed ID: 24811958
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a 2% climbazole shampoo for reducing Malassezia population sizes on the skin of naturally infected dogs.
Cavana P; Petit JY; Perrot S; Guechi R; Marignac G; Reynaud K; Guillot J
J Mycol Med; 2015 Dec; 25(4):268-73. PubMed ID: 26603053
[TBL] [Abstract][Full Text] [Related]
19. Ecotoxicity of climbazole, a fungicide contained in antidandruff shampoo.
Richter E; Wick A; Ternes TA; Coors A
Environ Toxicol Chem; 2013 Dec; 32(12):2816-25. PubMed ID: 23982925
[TBL] [Abstract][Full Text] [Related]
20. Use of a modified hair strand test to assess the antifungal activity kinetics of dog hair after a 2% climbazole shampoo application.
Petit JY; Cavana P; Thoumire S; Guillot J; Perrot S
Vet Dermatol; 2016 Jun; 27(3):148-e38. PubMed ID: 27072515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
